Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir Dipivoxil Extension Study for Korean CHB Patients
NCT00403585Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 2006
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adefovir dipivoxil in Chronic Hepatitis B (CHB), sponsored by GSK. Primary endpoint: Hepatitis B Virus (HBV) DNA Change From Baseline at 156 weeks. Started Jul 2006; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00403585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403585.